NCT06753942
- Conditions
- Blood-Borne Infections, Communicable Diseases, Female Urogenital Diseases, +20 more
- Locations
-
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
Clinical trial condition
Glomerulonephritis
Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.
26 public trials
2 recruiting studies
Glomerulonephritis trial results
NCT05505955
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Glomerulonephritis, +5 more
- Locations
-
- The Affiliated hospital of QingDao University Qingdao, Shandong, China
NCT03832114
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Glomerulonephritis, +5 more
- Locations
-
- Novartis Investigative Site Iowa City, Iowa, United States
- Novartis Investigative Site Montpellier, France
- Novartis Investigative Site Paris, France
- Novartis Investigative Site Essen, Germany
Completed
Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With Cystinuria
NCT03836144
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystinuria, Female Urogenital Diseases, +18 more
- Locations
-
- Eurpean Georges Pompidou Hospital Paris, Île-de-France Region, France
NCT05283057
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Glomerulonephritis, +10 more
- Locations
-
- Cairo university hospitals Cairo, Egypt
NCT03126201
- Conditions
- Disease Attributes, Disease Progression, Female Urogenital Diseases, +11 more
- Locations
-
- Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine Istanbul, Turkey (Türkiye)
NCT01093157
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Glomerulonephritis, +5 more
- Locations
-
- University Health Network- Toronto General Hospital Toronto, Ontario, Canada
NCT02700516
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Glomerulonephritis, +5 more
- Locations
-
- Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine Istanbul, Turkey (Türkiye)
- Division of Nephrology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine Istanbul, Turkey (Türkiye)
Completed
A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
NCT00426348
- Conditions
- Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Guangdong General Hospital Guangzhou, Guangdong, China
Completed
Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor
NCT00437463
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Glomerulonephritis, +5 more
- Locations
-
- Sanofi-Aventis Hong Kong